← Ishga qaytish
Ushbu ishga iqtibos qilgan ishlar
3 ta ish
Ish: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab
Kashfiyot
Xizmatlar
Ishlab chiquvchilar uchun
3 ta ish
Ish: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab